Related Experiment Video
Updated: Feb 7, 2026

Reduced Procedure Time and Variability with Active Esophageal Cooling During Radiofrequency Ablation for Atrial Fibrillation
Published on: August 25, 2022
Meningioangiomatosis: A review of the variable manifestations and complex pathophysiology
Christine Tomkinson1, Jian-Qiang Lu2
1Department of Medicine, Division of Neurology, McMaster University, Hamilton, Ontario, Canada.
Abstract:
Meningioangiomatosis (MA) is a rare, complex and heterogeneous disease of meningovascular proliferation that is found primarily in the leptomeninges and cerebral cortex but can involve subcortical white matter and other brain regions such as the cerebellum and deep gray matter. MA may be found in pediatric or adult populations and may be sporadic or neurofibromatosis-associated. The presentation of MA is highly variable: it may be associated with other neurological diseases; clinically presents on a spectrum from asymptomatic to seizures or focal deficits; radiologically presents with multifocal, tumor-like, or cystic lesions, or may appear normal; and pathologically may have cellular or vascular predominance. In this article, we review the various manifestations of MA including neurofibromatosis-associated MA, multifocal MA, cystic MA, and MA associated with meningioma, other brain tumors, focal cortical dysplasia, neurodegenerative changes, and post-radiation changes. The treatment of MA is also reviewed. While the pathogenesis of MA remains elusive, we discuss the proposed theories such as developmental, dysplastic, hamartomatous or reactive ethology in given variants. It is important for physicians to be aware of MA as more research on this complex entity is needed and timely diagnosis may benefit outcomes in patients with MA.
Insights
Meningioangiomatosis (MA) is a rare brain disease involving abnormal blood vessel and tissue growth. This review covers its diverse presentations, associations, and treatment, highlighting the need for physician awareness and further research.
Area of Science:
- Neuropathology
- Neuro-oncology
- Vascular Neurology
Background:
- Meningioangiomatosis (MA) is a rare, heterogeneous disease characterized by meningovascular proliferation.
- It primarily affects the leptomeninges and cerebral cortex but can involve other brain regions and occur in pediatric or adult populations.
- MA can be sporadic or associated with neurofibromatosis.
Purpose of the Study:
- To review the diverse clinical, radiological, and pathological manifestations of meningioangiomatosis.
- To discuss associated neurological diseases, tumor types, and conditions.
- To summarize current treatment approaches and proposed pathogenetic theories for MA.
Main Methods:
- Literature review of meningioangiomatosis (MA).
- Analysis of MA variants including neurofibromatosis-associated, multifocal, cystic, and those associated with other pathologies.
- Review of treatment strategies and pathogenetic hypotheses.
Main Results:
- MA presents with highly variable clinical symptoms, radiological findings, and pathological features.
- Manifestations include associations with meningioma, other brain tumors, focal cortical dysplasia, neurodegeneration, and post-radiation changes.
- Pathogenesis remains unclear, with theories suggesting developmental, dysplastic, hamartomatous, or reactive origins.
Conclusions:
- Physician awareness of MA's complexity and variability is crucial for timely diagnosis.
- Further research is needed to elucidate MA pathogenesis and improve patient outcomes.
- MA represents a spectrum of meningovascular proliferation requiring comprehensive understanding and management.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Pneumonia II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

